Search

Search Constraints

You searched for: Author/Creator Hoops, Timothy

Search Results

1. S770 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn's Disease: IBDQ in the SEAVUE Study. (October 2021)

3. S851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn's Disease: PROMIS-29 in the SEAVUE Study. (October 2021)

4. Ustekinumab IV Induction Results in Crohn's Disease Symptom Improvement Within the First Week in Anti‐TNF Refractory Patients: 730. (October 2017)

5. S823 The Impact of Treatment Switch Among Prevalent Patients With Crohn's Disease Treated With a First-Line Biologic: A U.S. Retrospective Claims Database Study. (October 2022)

6. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial. Issue 10342 (11th June 2022)

7. O30 Closure of perianal fistula in patients receiving ustekinumab in the SEAVUE and STARDUST trials. (19th June 2022)